The microarray patch market is projected to grow from USD 1,117.2 million in 2026 to USD 3,347.9 million by 2036, at a CAGR of 11.6%. Dissolving microneedle patches will dominate with a 48.0% market share, while vaccine delivery will lead the application segment with a 52.0% share.